Pieper Steven sold XERS
July 6, 2026 · Form 4 insider transaction
Pieper Steven sold 17,400 shares of Xeris Biopharma Holdings, Inc. at $8.50 per share, a transaction worth $147.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
17,400
Price
$8.50
Total value
$147.9K
InsiderPieper Steven
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 6, 2026
Filing dateJuly 7, 2026
Shares owned after1,393,653
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.; Includes 2,113 shares acquired on June 30, 2026 under the issuer's 2018 Employee Stock Purchase Plan, as amended.